Immunoreactivity of p63 in Monolayered and In Vitro Stratified Human Urothelial Cell Cultures Compared with Native Urothelial Tissue

European Urology

Volumn 53, Issue 5, 2008, Pages 1066-1073

  Feil, Gerhard ^a   Maurer, Sabine ^a   Nagele, Udo ^a   Krug, Jutta ^a   Bock, Conny ^a   Sievert, Karl Dietrich ^a   Stenzl, Arnulf ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cytokeratin 20; Epithelial differentiation; Fibroblast surface antigen; In vitro stratification; p63; Pancytokeratin; Tissue engineering; Uroplakin III; Urothelial monolayer; Urothelial multilayer

Indexed keywords

BIOLOGICAL MARKER; CYTOKERATIN 20; FIBROBLAST SURFACE ANTIGEN; MEMBRANE ANTIGEN; PANCYTOKERATIN; PROTEIN P63; UNCLASSIFIED DRUG; UROPLAKIN; UROPLAKIN III;

ARTICLE; BLADDER; CELL CULTURE; CELL DIFFERENTIATION; COMPARATIVE STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; KIDNEY PELVIS; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE ENGINEERING; URETER; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MIDDLE AGED; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 41149181161     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.10.026     Document Type: Article

References (33)

1. Lewis S.A. Everything you wanted to know about the bladder epithelium but were afraid to ask. Am J Physiol Renal Physiol 278 (2000) F867-F874
2. Southgate J., Harnden P., and Trejdosiewicz L.K. Culture of human urothelium. In: Freshney I., and Freshney M.G. (Eds). Culture of epithelial cells. 2nd ed. (2002), Wiley-Liss Inc., New York 381-399
3. Lavelle J., Meyers S., Ramage R., et al. Bladder permeability barrier: recovery from selective injury of surface epithelial cells. Am J Physiol Renal Physiol 283 (2002) F242-F253
4. Apodaca G. The uroepithelium: not just a passive barrier. Traffic 5 (2004) 117-128
5. Negrete H.O., Lavelle J.P., Berg J., Lewis S.A., and Zeidel M.L. Permeability properties of the intact mammalian bladder epithelium. Am J Physiol 271 (1996) F886-F894
6. Yang A., Kaghad M., Wang Y., et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2 (1998) 305-316
7. Levrero M., De Laurenzi V., Costanzo A., Gong J., Melino G., and Wang J.Y. Structure, function and regulation of p63 and p73. Cell Death Differ 6 (1999) 1146-1153
8. Irwin M.S., and Kaelin W.G. p53 family update: p73 and p63 develop their own identities. Cell Growth Differ 12 (2001) 337-349
9. Little N.A., and Jochemsen A.G. p63. Int J Biochem Cell Biol 34 (2002) 6-9
10. Candi E., Dinsdale D., Rufini A., et al. TAp63 and DeltaNp63 in cancer and epidermal development. Cell Cycle 6 (2007) 274-285
11. Koster M.I., Kim S., Mills A.A., DeMayo F.J., and Roop D.R. p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev 18 (2004) 126-131
12. Wu G., Nomoto S., Hoque M.O., et al. DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res 63 (2003) 2351-2357
13. Mills A.A., Zheng B., Wang X.J., Vogel H., Roop D.R., and Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398 (1999) 708-713
14. Yang A., Schweitzer R., Sun D., et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398 (1999) 714-718
15. Senoo M., Pinto F., Crum C.P., and McKeon F. p63 is essential for the proliferative potential of stem cells in stratified epithelia. Cell 129 (2007) 523-536
16. Koster M.I., Dai D., Marinari B., et al. p63 induces key target genes required for epidermal morphogenesis. Proc Natl Acad Sci U S A 104 (2007) 3255-3260
17. Park B.J., Lee S.J., Kim J.I., et al. Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res 60 (2000) 3370-3374
18. Southgate J., Harnden P., and Trejdosiewicz L.K. Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications. Histol Histopathol 14 (1999) 657-664
19. Wu X.R., Lin J.H., Walz T., et al. Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins. J Biol Chem 269 (1994) 13716-13724
20. Liang F.X., Riedel I., Deng F.M., et al. Organization of uroplakin subunits: transmembrane topology, pair formation and plaque composition. Biochem J 355 (2001) 13-18
21. Feil G., Christ-Adler M., Maurer S., et al. Investigations of urothelial cells seeded on commercially available small intestine submucosa. Eur Urol 50 (2006) 1330-1337
22. Langner C., Ratschek M., Tsybrovskyy O., Schips L., and Zigeuner R. P63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors. J Histochem Cytochem 51 (2003) 1097-1099
23. Di Como C.J., Urist M.J., Babayan I., et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 8 (2002) 494-501
24. McKeon F. p63 and the epithelial stem cell: more than status quo?. Genes Dev 18 (2004) 465-469
25. Urist M.J., Di Como C.J., Lu M.L., et al. Loss of p63 expression is associated with tumor progression in bladder cancer. Am J Pathol 161 (2002) 1199-1206
26. Saito K., Kawakami S., Okada Y., et al. Spatial and isoform specific p63 expression in the male human urogenital tract. J Urol 176 (2006) 2268-2273
27. Comperat E., Camparo P., Haus R., et al. Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 cases. Virchows Arch 448 (2006) 319-324
28. King K.E., and Weinberg W.C. p63: defining roles in morphogenesis, homeostasis, and neoplasia of the epidermis. Mol Carcinog 46 (2007) 716-724
29. Southgate J., Hutton K.A., Thomas D.F., and Trejdosiewicz L.K. Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab Invest 71 (1994) 583-594
30. Atala A., Bauer S.B., Soker S., Yoo J.J., and Retik A.B. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367 (2006) 1241-1246
31. Baumert H., Mansouri D., Fromont G., et al. Terminal urothelium differentiation of engineered neoureter after in vivo maturation in the "omental bioreactor". Eur Urol (2007) [Epub ahead of print]
32. Fraser M., Thomas D.F., Pitt E., Harnden P., Trejdosiewicz L.K., and Southgate J. A surgical model of composite cystoplasty with cultured urothelial cells: a controlled study of gross outcome and urothelial phenotype. BJU Int 93 (2004) 609-616
33. Shiroyanagi Y., Yamato M., Yamazaki Y., Toma H., and Okano T. Urothelium regeneration using viable cultured urothelial cell sheets grafted on demucosalized gastric flaps. BJU Int 93 (2004) 1069-1075